Concomitant Use of Radiotherapy and Integrated Exercise - Lung Cancer

Recruiting N/A Interventional Study
Non Small Cell Lung Cancer Radiation Therapy Patient Stage II/III
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
10 (estimated)
Sponsor
University of Deusto · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Study objective and procedures The objective of CURIE-LC is to evaluate the feasibility (i.e., whether it is possible and safe) of carrying out a comprehensive exercise program during combined radiotherapy and chemotherapy in patients with lung cancer. The study will assess whether patients can adhere to the exercise program while receiving oncologic treatment and will explore its effects on phys…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Histological diagnosis of non-small cell lung cancer (NSCLC) at stage II-III (locally advanced), unresectable/inoperable. * Candidate for radical radiotherapy with concomitant chemotherapy, with or without maintenance Durvalumab. * ECOG performance status ≤2 (or Karnofsky inde…
Contacts

Jurgi Zulaika

+34 943 32 66 00

jurgi.zulaika@deusto.es

CONTACT